Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre‐eclampsia
Authors:
- 1 February 1997
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 104 (2) , 223-228
Abstract
Objective To determine whether vascular endothelial growth factor (VEGF) concentrations are altered in pre‐eclampsia.Design Serum was prepared from peripheral venous blood and stored at −70°C. Serum VEGF concentrations were measured by ELISA.Setting University of Glasgow Department of Obstetrics and Gynaecology, Royal Infirmary, Glasgow.Participants Twenty‐two healthy nonpregnant volunteer women, 34 normal pregnant women and 34 women with pre‐eclampsia were studied.Results Serum concentrations of VEGF were significantly lower in normal pregnant women (median value 12.89 pg/mL) than in nonpregnant women (median value 166 pg/mL; P < 0.0001). In pre‐eclampsia VEGF concentrations were significantly lower (median value 2.34 pg/mL) than normal pregnancies (P < 0.0001). Postpartum concentrations of VEGF in the group complicated by pre‐eclampsia (median value 76.42 pg/mL) were not significantly different from nonpregnant values (P= 0.2).Conclusions Our results show that serum concentrations of VEGF are suppressed in pregnancy and further reduced in pre‐eclampsia. Further studies to elucidate the mechanisms which lead to a reduction in VEGF concentrations may provide new clues to the aetiology of this disorder.Keywords
This publication has 49 references indexed in Scilit:
- AUTHORS' REPLYBJOG: An International Journal of Obstetrics & Gynaecology, 1995
- Pre-eclampsiaJournal Of Hypertension, 1994
- The use of Butcher series in the analysis of Newton-like iterations in Runge–Kutta formulasApplied Numerical Mathematics, 1994
- Modalities for reducing interleukin 1 activity in diseaseImmunology Today, 1993
- Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factorBiochemical and Biophysical Research Communications, 1992
- The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth FactorScience, 1992
- Molecular and biological properties of the vascular endothelial growth factor family of proteinsEndocrine Reviews, 1992
- Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitroImmunology Today, 1991
- Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: Binding, internalization, degradation, and biological effectsJournal of Cellular Physiology, 1991
- Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cellsBiochemical and Biophysical Research Communications, 1989